XML 23 R17.htm IDEA: XBRL DOCUMENT v3.19.3
Note 11 - Derivative Instruments; Fair Value
 9 Months Ended
Sep. 30, 2019
Notes to Financial Statements  
Derivatives and Fair Value [Text Block]
Note
11
- Derivative Instruments; Fair Value
 
The Company accounts for derivative instruments in accordance with U.S. GAAP, which requires that all derivative instruments be recognized on the balance sheet at fair value. We
may
enter into interest rate swaps to fix the interest rate on a portion of our variable interest rate debt to reduce the potential volatility in our interest expense that would otherwise result from changes in market interest rates. Our derivative instruments are recorded at fair value and are included in accrued liabilities of our consolidated balance sheet. Our accounting policies for these instruments are based on whether they meet our criteria for designation as hedging transactions, which include the instrument’s effectiveness, risk reduction and, in most cases, a
one
-to-
one
matching of the derivative instrument to our underlying transaction. As of
September 30, 2019,
we had
no
such instrument. The only derivative instrument, terminated during
2019,
was accounted for as a hedge. Changes in fair value for the respective periods were recognized in the consolidated statement of operations.
 
The interest rate swap we entered into
December 14, 2017
had a
three
year term (ending
December 14, 2020)
and a notional amount of
$3
million. The Company purchased a
2.25%
fixed rate in exchange for the variable rate on a portion of the notes payable under the PNC Agreements, which was
1.47%
at time of execution. The swap was terminated during
2019
as a result of the
first
forbearance agreement with the bank.